miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT

MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice

(2017) Heng Wu et al.   HEPATOLOGY

Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells

(2017) Yuichi Sesumi et al.   LUNG CANCER

ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis

(2017) Kuo-Liang Chiu et al.   Oncotarget

miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met

(2017) Xiaonian Cao et al.   Scientific Reports

Longer warm ischemia can accelerate tumor growth through the induction of HIF-1α and the IL-6-JAK-STAT3 signaling pathway in a rat hepatocellular carcinoma model

(2016) Yuhei Hamaguchi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET

(2016) Xi Chen et al.   Oncology Letters

MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway

(2016) Jingjin Jiang et al.   Oncotarget

Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer

(2016) Demin Jiao et al.   Molecular Therapy-Oncolytics

MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer

(2015) Qiang Zhen et al.   CYTOGENETIC AND GENOME RESEARCH

Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis

(2015) Qing-yong Chen et al.   Molecular BioSystems

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis

(2015) Kuo-Liang Chiu et al.   Scientific Reports

MiR-130a Overcomes Gefitinib Resistance by Targeting Met in Non-Small Cell Lung Cancer Cell Lines

(2014) Yong-Ming Zhou et al.   Asian Pacific Journal of Cancer Prevention

MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells

(2014) Qian-Qian Yu et al.   BIOMEDICINE & PHARMACOTHERAPY

MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET

(2014) Jian-Ya Zhou et al.   CANCER LETTERS

Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines

(2014) William S. Holland et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Nrf2 augments skeletal muscle regeneration after ischaemia-reperfusion injury

(2014) Othman Al-Sawaf et al.   JOURNAL OF PATHOLOGY

miR-1 Induces Growth Arrest and Apoptosis in Malignant Mesothelioma

(2013) Yue Xu et al.   CHEST

Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma

(2013) E. Nadal et al.   CLINICAL CANCER RESEARCH

Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis

(2013) Anju Singh et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met

(2013) Wenting Luo et al.   PLoS One

Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer

(2012) Shinji Takeuchi et al.   AMERICAN JOURNAL OF PATHOLOGY

Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny

(2012) Kenichi Suda et al.   CANCER AND METASTASIS REVIEWS

Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor-Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer

(2012) W. Wang et al.   CLINICAL CANCER RESEARCH

miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish

(2012) C. Stahlhut et al.   DEVELOPMENT

Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer

(2012) Marc Campayo et al.   EUROPEAN RESPIRATORY JOURNAL

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

(2012) Y-N Liu et al.   ONCOGENE

Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell lines

(2011) H Li et al.   Advances in Medical Sciences

Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

(2011) I. S. Donev et al.   CLINICAL CANCER RESEARCH

c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma

(2011) Hanning You et al.   HEPATOLOGY

MicroRNA-206 Is Associated With Invasion and Metastasis of Lung Cancer

(2010) Xiaochen Wang et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

let-7 and miR-17-92: Small-sized major players in lung cancer development

(2010) Hirotaka Osada et al.   CANCER SCIENCE

Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs

(2010) Jin-Haeng Chung et al.   LUNG CANCER

Nuclear Receptor SHP Activates miR-206 Expression via a Cascade Dual Inhibitory Mechanism

(2009) Guisheng Song et al.   PLoS One

MicroRNA-206: The skeletal muscle-specific myomiR

(2008) J MCCARTHY   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis

(2008) J. Datta et al.   CANCER RESEARCH

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations

(2008) S. Yano et al.   CANCER RESEARCH

Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer

(2008) Mohd W. Nasser et al.   JOURNAL OF BIOLOGICAL CHEMISTRY